Emyria selected to join Palantirs Foundry Builders Program
Filed with ASX · · 6 pages · English
● Palantir Technologies (NYSE:PLTR, market cap: US$54B), co-founded by Peter Thiel (PayPal), is a world leader in data platforms for major organisations and institutions with complex and sensitive data environments including the FDA, National Institutes of Health and Sanofi ● The Palantir Foundry Builders program was established to allow select companies access to powerful and highly secure data i
Earlier from Emyria
- Novel MDMA Analogue Screening Program Advanced
- Emyria Expands Psychiatry Advisory for Psychedelics and MDMA
- MDMA-analogues Show Promise for Parkinsons Disease
- Emyria Engages Calvert Labs for Preclinical CBD studies
- Emyria Appoints Expert Neuropharmacologist for MDMA Program
Later from Emyria
- MDMA Analogue Development Milestone
- Emyria Welcomes Tattarang as Strategic Investor
- Emyria receives $1,162,000 R&D Tax Incentive Refund
- Positive initial MDMA-analogue screening results
- Positive animal data for Emyrias ultra-pure CBD capsule
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria